25 Feb, 2020 10:04 AM
Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce that it has appointed US-based specialist healthcare investor, Jake Nunn to the position of ...read more
24 Feb, 2020 08:19 AM
Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce that its Sleep Treatment Platform will be included in a range of OSA treatment solutions bei...read more
14 Feb, 2020 09:48 AM
Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is delighted to announce that it has been notified by the Pricing, Analysis and Coding (PDAC) contractors which sup...read more
16 Dec, 2019 09:49 AM
Oventus Medical Ltd or the Company (ASX: OVN) is pleased to announce that it has appointed medical device industry expert, Paul Molloy to the Board as Non-Executive Director. Mr Molloy replaces co f...read more
15 Nov, 2019 08:25 AM
Key topics in this newsletter include: A commercialisation update on the Company’s O2Vent sleep treatment platform for patients with Obstructive Sleep Apnoea, which includes an overview of the...read more
06 Nov, 2019 03:39 PM
R&D Tax rebate received
Brisbane, Australia 6th November 2019: Oventus Medical Ltd (ASX: OVN) is pleased to announce that is has received a cash refund of $828,000 from the Australian Taxation Of...read more
01 Nov, 2019 10:15 AM
Brisbane, Australia 1 November 2019: Oventus Medical Ltd or the Company (ASX: OVN) is pleased to invite shareholders to participate in the 2019 Annual General Meeting (AGM) via a dial-in facility, to ...read more
